The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Apolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle age
Abstract
Objective: To study the prevalence and age dependency of senile plaques (SP) and neurofibrillary tangles (NFT), the brain changes characteristic of Alzheimer disease (AD), and their association with apolipoprotein E (APOE) genotypes in a community‐dwelling normal population. Methods: This neuropathological study used both silver staining and Aβ immunohistochemistry in brain tissue microarrays, including SP coverage and NFT counts from frontal cortex and hippocampus, and APOE genotyping, and was performed on a consecutive prospective series of 603 subjects (aged between 0 and 97 years) of an unselected population living outside of institutions. Cases were subjected to autopsy following sudden or unexpected out‐of‐hospital death, covering 22.1% of the mortality of Tampere, Finland and its surroundings. None died of AD, although 22 (3.7%) were demented and 10 (1.7%) had memory problems. Results: Of the series, 30.8% had SP, and 42.1% had NFT; these occurred more commonly among females and showed a strong relationship with age. Both changes had already appeared at around 30 years of age, reaching an occurrence of almost 100% in the oldest. SP were more frequent in APOE ϵ4‐carriers compared with noncarriers in every age group except the oldest (>90 years). The difference was most evident during the ages 50 to 59 years, where 40.7% of ϵ4‐carriers had SP, compared with 8.2% in noncarriers (odds ratio, 8.39; 95% confidence interval, 2.55–27.62). The difference in NFT prevalence between APOE genotypes was not statistically significant in any age group. Interpretation: The brain changes associated with AD may already begin developing early in middle age, especially among APOE ϵ4 carriers. Ann Neurol 2009;65:650–657
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is strong experimental evidence that the APOE isoforms are major determinants of the amount and quality of amyloid-β peptide (Aβ) and amyloid burden in the brain that develops during aging.15–17”
From AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease (2018) · cites this paper as [17]
In the citing paper
“In AD, its specific role in promoting β-amyloid (Aβ) plaque pathology is, however, well established (Fleisher et al, 2013; Kok et al, 2009; Murphy et al, 2013; Schmechel et al, 1993).”
From APOE from astrocytes restores Alzheimer’s Aβ-pathology and DAM-like responses in APOE deficient microglia (2024) · cites this paper as Kok et al, 2009
In the citing paper
“In AD patients, APOE4 enhances Aβ deposition, where 40.7% of middle-aged APOE ε4 carriers featured senile plaques, compared to 8.2% non-carriers identified with senile plaques [459].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [459]
Citations
Cites
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920
Apolipoprotein E: Far More Than a Lipid Transport Protein
Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291
Braak, F., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 769
Research works printed but not linked: 1
- O'Brien J, 2000, Dementia
Cited by
Sorted by citations
Items 201–299 of 299
Midlife memory improvement predicts preservation of hippocampal volume in old age
Borghesani, P. R., Weaver, K. E., Aylward, E., Richards, A. L., Madhyastha, T. M., Kahn, A. R., Liang, O., Ellenbogen, R. L., Beg, M. F., Schaie, K. W., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.026 · Cited by 12
Modeling regional vulnerability to Alzheimer pathology
Royall, D. R., Palmer, R. F., Petrovitch, H., Ross, G. W., Masaki, K., & White, L. R. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.028 · Cited by 12
Gingival Crevicular Fluid as Biomarker’s Source for Alzheimer’s Disease
Sansores‐España, L. D., Morales, F. C., Arriola‐Pacheco, F., Astorga, J., Paula-Lima, A. C., Carrillo-Ávila, A., Melgar‐Rodríguez, S., Martínez-Aguilar, V. M., & Díaz‐Zúñiga, J. (2021) · Odovtos - International Journal of Dental Sciences · doi:10.15517/ijds.2022.49232 · Cited by 13
Regulation of Alzheimer's disease-associated proteins during epileptogenesis
von Rüden, E., Zellinger, C., Gedon, J., Walker, A., Bierling, V., Deeg, C. A., Hauck, S. M., & Potschka, H. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.08.037 · Cited by 11
Etnier, J. L., Labban, J. D., Karper, W. B., Wideman, L., Piepmeier, A. T., Shih, C.-H., Castellano, M., Williams, L. M., Park, S.-Y., Henrich, V. C., et al. (2015) · Journal of Aging and Physical Activity · doi:10.1123/japa.2014-0221 · Cited by 12
Sundermann, E. E., Wang, C., Katz, M. J., Zimmerman, M. E., Derby, C. A., Hall, C. B., Ozelius, L. J., & Lipton, R. B. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.006 · Cited by 13
Research Progress of Lipid Metabolism-Mediated Neuroinflammation in Alzheimer’s Disease
Shen, Y., Wang, X., Liu, X., Wang, G., Hou, X., & Zhou, X. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01648-9 · Cited by 12
The Role of RIN3 Gene in Alzheimer’s Disease Pathogenesis: a Comprehensive Review
Meshref, M. M., Ghaith, H. S., Hammad, M. A., Shalaby, M. M. M., Ayasra, F., Monib, F. A., Attia, M. S., Ebada, M. A., Elsayed, H., Shalash, A., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03802-0 · Cited by 12
Circadian rhythms are associated with higher amyloid-β and tau and poorer cognition in older adults
Eckhardt, J. L., Isenberg, L., Aslanyan, V., Monreal, T. K., Stradford, J., Fenton, L. E., Contreras, J. A., Mack, W. J., & Pa, J. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf322 · Cited by 13
Xiong, C., Luo, J. R., Morris, J. C., & Bateman, R. J. (2017) · Biostatistics & Epidemiology · doi:10.1080/24709360.2017.1331821 · Cited by 10
The Role of APOE and NF-κB in Alzheimer’s Disease
Davies, D. A. (2021) · Immuno · doi:10.3390/immuno1040027 · Cited by 10
Duan, H., Sun, Y., Liu, Q., Fu, J., Huang, L., Wang, Z., Zhao, J., Li, Z., Li, W., Liu, H., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15269 · Cited by 10
Sato, Y., Bernier, F., Yamanaka, Y., Aoshima, K., Oda, Y., Ingelsson, M., Lannfelt, L., Miyashita, A., Kuwano, R., & Ikeuchi, T. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2014.11.009 · Cited by 10
The effect of β‐amyloid positivity on cerebral metabolism in cognitively normal seniors
Bozoki, A., Zdanukiewicz, M., Zhu, D. C., & Initiative, A. D. N. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.003 · Cited by 9
Influence of Water Quality on Cholesterol‐Induced Tau Pathology: Preliminary Data
Sparks, D. L., Ziolkowski, C. H. J., Lawmaster, T., & Martin, T. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/987023 · Cited by 9
Werhane, M. L., Thomas, K. R., Edmonds, E. C., Bangen, K. J., Tran, M., Clark, A. L., Nation, D. A., Gilbert, P. E., Bondi, M. W., Delano‐Wood, L., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170918 · Cited by 9
Mahanta, A. K., Chaulagain, B., Gothwal, A., & Singh, J. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00465 · Cited by 10
Lee, B. H., Puri, T. A., & Galea, L. A. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819344-0.00010-7 · Cited by 8
Carlos, A. F., Machulda, M. M., Rutledge, M. H., Nguyen, A. T., Reichard, R. R., Baker, M., Rademakers, R., Dickson, D. W., Petersen, R. C., & Josephs, K. A. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221094 · Cited by 11
The molecular pathology of neurodegenerative and psychiatric disorders
Yan, P., Deng, Y. M., Su, X., Kong, H., Zhang, Y., Li, W., & Kong, E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00007-5 · Cited by 8
A profile of brain reserve in adults at genetic risk of Alzheimer's disease
Coughlan, G., Zhukovsky, P., Voineskos, A. N., & Grady, C. L. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12208 · Cited by 9
Neurobiological effects of music-making interventions for older adults: a systematic review
Espinosa, N., Schrire, Z. M., McKinnon, A. C., Almgren, H., Mowszowski, L., & Naismith, S. L. (2025) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-03006-7 · Cited by 9
Molecular Framework of the Onset and Progression of Skeletal Muscle Aging
Horlem, T., Carvalhal, S. R. S., Bonatto, S. J. R., & Fernandes, L. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010145 · Cited by 7
Xiong, C., McCue, L. M., Buckles, V., Grant, E., Agboola, F., Coble, D. W., Bateman, R. J., Fagan, A. M., Benzinger, T. L. S., Hassenstab, J. J., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12912 · Cited by 7
Beyond diagnosis: What biomarkers are teaching us about the “bio”logy of Alzheimer disease
Rabinovici, G. D., & Roberson, E. D. (2010) · Annals of Neurology · doi:10.1002/ana.22020 · Cited by 7
Small molecule biomarkers in Alzheimer’s disease
Kim, M. G., & Legido‐Quigley, C. (2018) · OCL · doi:10.1051/ocl/2018027 · Cited by 8
APOE ε2 and presymptomatic stage Alzheimer disease
Caselli, R. J., & Dueck, A. C. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ff94f7 · Cited by 7
Fat and Lipid Metabolism and the Involvement of Apolipoprotein E in Alzheimer's Disease
Hone, E., Lim, F., & Martins, I. J. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch7 · Cited by 8
Dietary Glycemic Load and Plasma Amyloid-β Biomarkers of Alzheimer’s Disease
Gentreau, M., Michel Raymond, A., Samieri, C., Chuy, V., Féart, C., Berticat, C., & Artéro, S. (2022) · Nutrients · doi:10.3390/nu14122485 · Cited by 12
Vascular Heparan Sulfate and Amyloid-β in Alzheimer’s Disease Patients
McMillan, I. O., Gearing, M., & Wang, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073964 · Cited by 7
APOE Is Associated With Serum Tau Following Uncomplicated Mild Traumatic Brain Injury
Lippa, S. M., Lange, R. T., Dalgard, C. L., Soltis, A. R., Guedes, V. A., Brickell, T. A., French, L. M., & Gill, J. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.816625 · Cited by 7
Drake, J. A., Jakicic, J. M., Rogers, R. J., Aghjayan, S. L., Stillman, C. M., Donofry, S. D., Roecklein, K. A., Lang, W., & Erickson, K. I. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.1001229 · Cited by 6
Effects of Apolipoprotein E Genotype on the Off-Line Memory Consolidation
Wang, D.-Y., Han, X., Li, S., Liu, D., Yan, C., Zuo, X., Zhu, C.-Z., Yong He, A., Kiviniemi, V. J., & Zang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051617 · Cited by 6
Lifespan brain activity, b-amyloid, and Alzheimer's disease
Jagust, W. J., & Mormino, E. C. (2011) · Cited by 6
Saleh, O. M., Albakri, K. A., Altiti, A., Abutair, I., Shalan, S. S., Mohd, O. B., Negida, A., Mushtaq, G., & Kamal, M. A. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230519113201 · Cited by 5
Liu, Y., Initiative, A. D. N., Wang, X.-J., Tan, L., Tan, C., & Xu, W. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230516 · Cited by 5
Elshazly, A. M., Sinanian, M. M., Elimam, D. M., & Zakaria, S. (2023) · Neuroglia · doi:10.3390/neuroglia4030014 · Cited by 5
Fray, S., Achouri-Rassas, A., Belal, S., & Messaoud, T. B. (2022) · Journal of Genetics · doi:10.1007/s12041-022-01384-9 · Cited by 4
Parsimonious EBM: Generalising the event-based model of disease progression for simultaneous events
Parker, C. S., Oxtoby, N. P., Young, A. L., Initiative, A. D. N., Alexander, D. C., & Zhang, H. G. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121162 · Cited by 6
Does an Alzheimer's disease susceptibility gene influence the cognitive effects of cancer therapy?
Caselli, R. J. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24768 · Cited by 4
Wijesinghe, P., Wijeweera, G., & de Silva, K. R. D. (2023) · Healthy ageing and longevity · doi:10.1007/978-3-031-22468-3_7 · Cited by 3
Prabhakaran, D., Grant, C. W., Pedraza, O., Caselli, R. J., Athreya, A. P., & Chandler, M. J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230556 · Cited by 3
Robert, J., Cheng, W. H., Hayat, A., Ward-Able, T., & Wellington, C. L. (2015) · Clinical Lipidology · doi:10.2217/clp.14.64 · Cited by 3
Gao, Y., Li, X., Liu, X., Zhao, Q., Che, X., Guo, Q., Ren, R., & Wang, G. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.05.51 · Cited by 2
He, M., Lian, T., Guo, P. F., Zhang, W., Zhang, Y., Huang, Y. M., Liu, G., Guan, H., Li, J., Luo, D., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14440 · Cited by 2
Agitation in Patients with Dementia - Challenges in Diagnosis and Treatment
Sommer, O. H. (2010) · NORA - Norwegian Open Research Archives · Cited by 3
Age-Related Memory Decline and the APOE ε4 Effect
Ma, L., Zhao, G., & Feng, X. (2009) · New England Journal of Medicine · doi:10.1056/nejmc091640 · Cited by 3
Daneshvar, D. H., Nowinski, C. J., Abdolmohammadi, B., Luster, C. B., Uretsky, M., Martin, B. M., Palmisano, J. N., Weuve, J., McClean, M. D., Cherry, J. D., et al. (2026) · BMJ · doi:10.1136/bmj-2026-100418 · Cited by 17
Situmeang, R., Wahjoepramono, E. J., Kaelan, C., Purba, J. S., Suhadi, B., As’ád, S., Aliah, A., Patellongi, I. J., & Wahid, S. (2016) · Medical Journal of Indonesia · doi:10.13181/mji.v25i1.1255 · Cited by 2
Harrison, E. M., Maki, P. M., Chang, Y., Wu, M., Kamboh, M. I., Aizenstein, H. J., & Thurston, R. C. (2026) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2026.2647965 · Cited by 2
Bernocchi, F., Bonomi, C. G., Poli, M., Donna, M. G. D., Terrinoni, A., Motta, C., & Martorana, A. (2026) · Neurological Sciences · doi:10.1007/s10072-026-08973-x · Cited by 2
Türk Popülasyonunda APOE Polimorfizmleri ve Alzheimer Hastalığı Arasındaki İlişki
Çilingir, O., Adapınar, B. D. Ö., Aras, B. D., Gökalp, E. E., Özkan, S., Arslan, S., Haziyeva, K., Kocagil, S., Bilgin, M., & Artan, S. (2019) · OSMANGAZİ JOURNAL OF MEDICINE · doi:10.20515/otd.553900 · Cited by 2
[18F] FBB cortical uptake is not related to the age of onset of Alzheimer’s disease
Chiaravalloti, A., Barbagallo, G., Castellano, A. E., Ricci, M., Ciccariello, G., Ursini, F., D’Ascenzo, N., Xie, Q., & Schillaci, O. (2019) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001131 · Cited by 2
Korthauer, L. E., Blujus, J. K., Awe, E., Frahmand, M., Prost, R. W., & Driscoll, I. F. (2021) · Brain Imaging and Behavior · doi:10.1007/s11682-021-00573-x · Cited by 2
Predicting Cognitive Decline in Older Adults Through Multi-Voxel Pattern Analysis
Hantke, N. C. (2014) · e-Publications@Marquette (Marquette University) · Cited by 2
Perani, D. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.8343973.8791070 · Cited by 2
Fused multi-modal similarity network as prior in guiding brain imaging genetic association
He, B., Xie, L., Varathan, P., Nho, K. T., Risacher, S. L., Saykin, A. J., Yan, J., & Initiative, T. A. D. N. (2023) · Frontiers in Big Data · doi:10.3389/fdata.2023.1151893 · Cited by 3
Zhang, B., Shi, C., Zhao, J., Hua, Q., Zhang, H., Gao, H., Qian, Y., Cha, J., Li, J., Chen, J., et al. (2026) · Exploration · doi:10.1002/exp2.70160 · Cited by 1
Burma, J. S., Nel, J. H., Cheung, H., Hofforth, D., Zala, D., Hayden, A., Ronksley, P. E., Carty, C. L., Chang, M., Gross, A. L., et al. (2026) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2026.101250 · Cited by 2
Cell-type-specific APOE4 cascade across the Alzheimer’s disease continuum
Shostak, D. M., Liang, Z., & Huang, Y. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.024 · Cited by 1
Cruz-Sesé, J., Miron-Alcala, M., Alfonso-Triguero, M., Olalde, J., Ruiz, L., Galbis-Gramage, N., Cortés, L., Escobar, L., Preman, P., Snellinx, A., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117803 · Cited by 1
Cognitive Aging and the Transition to Early Alzheimer’s Disease
Mormino, E. C., & Jagust, W. J. (2024) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190917982.013.59 · Cited by 1
Copolymer-1 as a potential therapy for mild cognitive impairment
Abraham, D. I., Salazar, F. E., & Ibarra, A. (2022) · Brain and Cognition · doi:10.1016/j.bandc.2022.105892 · Cited by 1
GENETIC VARIANTS PREDISPOSING TO CARDIAC ARRHYTHMIA DISORDERS AND SUDDEN CARDIAC DEATH
Lahtinen, A. M. (2012) · Työväentutkimus Vuosikirja
The role of the medial temporal lobe in discriminating complex object and scene stimuli
Shine, J. P. (2013) · ORCA Online Research @Cardiff (Cardiff University)
Miettinen, T. (2015) · Tampere University Institutional Repository (Tampere University)
Brain Aging as a Cause of Alzheimer’s Disease
Suzuki, T., Kimura, A., Chiba, K., Nakaya, T., & Hata, S. (2015) · Springer eBooks · doi:10.1007/978-4-431-55763-0_18
Pathological Consequences of Aβ From Extracellular to Intraneuronal
D’Andrea, M. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804256-4.00004-8
Fitzgerald, Ó. S., Barreto, G., & Lopera-Restrepo, F. (2013)
Wagle, J. (2011) · NORA - Norwegian Open Research Archives
Munger, E. L. (2016) · OhioLink ETD Center (Ohio Library and Information Network)
The effect of extraocular light on brain activity
Kovalainen, A. (2018) · Tampere University Institutional Repository (Tampere University)
AXL receptor tyrosine kinase regulates Apolipoprotein E expression
Zhao, W. (2019) · cIRcle (University of British Columbia) · doi:10.14288/1.0372324
Aging, cognitive ability and the risk of dementia in the Helsinki Birth Cohort Study
Rantalainen, V. (2019) · Työväentutkimus Vuosikirja
Nanolipidic Carriers as Potential Drug Delivery Vehicles in Alzheimer’s Disease
Talegaonkar, S., Gautam, N., Varshney, V., Sharma, S., & Bhattacharyya, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-30930-5_13
Investigating the role of normal and abnormal beta-amyloid processing in cognition
Freeman, T. J. (2019) · ORCA Online Research @Cardiff (Cardiff University)
Fernandez, F., & Andrews, J. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815854-8.00009-4
The interactive impact of omega-3 fatty acids, APOE genotype and sex hormones on cognition
Pontifex, M. G. (2020) · UEA Digital Repository (University of East Anglia)
Xiong, C., McCue, L. M., Buckles, V., Grant, E., Agboola, F., Coble, D., Bateman, R. J., Fagan, A. M., Benzinger, T. L. S., Hassenstab, J. J., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3928499
Liposomes: An Emerging Carrier for Brain Targetting and DeliveryPreprint
Pandian, S. R. K., Vijayakumar, K. K., Murugesan, S., & Kunjiappan, S. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3988692
Age-related cytoskeletal pathologies
Wijesinghe, P. (2020) · doi:10.26481/dis.20202508pk
Rosenberg, G. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823455-6.00006-7
Peixoto, H., Rodrigues, R., & Nunes, S. (2023) · Journal of Student Research · doi:10.47611/jsr.v12i1.1864
Cruz-Sesé, J., Miron-Alcala, M., Alfonso-Triguero, M., Olalde, J., Ruiz, L., Galbis-Gramage, N., Cortes, L., Escobar, L., Preman, P., Snellinx, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.28.635271
Farmer, B. C., Williams, H. C., Devanney, N. A., Piron, M. A., Nation, G. K., Carter, D. J., Walsh, A. E., Khanal, R., Young, L. E. A., Kluemper, J. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16575414
Associations Among miR-33, APOE ε4, and Metabolic Markers in Down Syndrome YouthPreprint
Ocampo, K. E., Espinoza, W. G., Acosta, T. S., Villalobos, S. A., Ontiveros, S. A. B., López, R. Z., Villarreal, M. P., Calderón-Zamora, L., Guadrón‐Llanos, A. M., Rojo, C. A., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8845542/v1
APOE genotype and astrocyte activity collectively influence AD biomarkers and Aβ burden
Chen, W., Su, F., Kong, H., Wang, Y., Yi, C., Zheng, Y., Fang, Y., Shi, X. D., Lin, Y., Zhou, J., et al. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150283
Tomadesso, C. (2018) · theses.fr (ABES) · doi:10.70675/7fad6418zff81z49c7z984dz63aa2e44d7fc
Apoprotein E: Structural insights functionality and genetic variability
Tewari, S., & Ranade, S. D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40563-1.00008-9
APOE ε4 and late-onset Alzheimer's disease in Syria: A case-control study
Labbad, I., Youssef, L. A., Rustom, M. J., & Agha, M. S. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261475340
Gene therapy in Alzheimer’s disease (AD)
Bemanalizadeh, M., Ashrafi, M., Eslami, M., Moein, S., Kazemi, A., & Mansouri, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40467-2.00014-2
Holcomb, E. M. (2013) · Human Biology
Metadata
- Authors
- Kok, E., Haikonen, S., Luoto, T., Huhtala, H., Goebeler, S., Haapasalo, H., & Karhunen, P. J.
- Affiliations
- Tampere University (FI)
- Tampere University Hospital (FI)
- Corresponding author
- Kok, Eloise
- Haikonen, Satu
- Luoto, Teemu
- Huhtala, Heini
- Goebeler, Sirkka
- Haapasalo, Hannu
- Karhunen, Pekka J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2009-06
- Volume
- 65
- Issue
- 6
- Pages
- 650-657
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2002776021
- Cited by
- 299
- References
- 39
- Citations by year
- 2026: 12 · 2025: 9 · 2024: 9 · 2023: 17 · 2022: 21 · 2021: 20 · 2020: 16 · 2019: 25 · 2018: 15 · 2017: 13 · 2016: 22 · 2015: 13 · 2014: 21 · 2013: 16 · 2012: 22
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, apolipoprotein E, APOE ε4, amyloid plaques, neurofibrillary tangles, middle age (human life stage), age-related prevalence, frontal cortex, hippocampus, sex differences, community-dwelling population, autopsy
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Aging, Alzheimer Disease, Apolipoproteins E, Child, Child, Preschool, Female, Genetic Carrier Screening, Humans, Infant, Infant, Newborn, Male, Middle Aged, Prospective Studies, Cohort Studies, Apolipoprotein E4, Young Adult, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
